Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia

Placenta

Volumn 35, Issue 9, 2014, Pages 718-723

  Kappou, D ^a,b   Sifakis, S ^b   Androutsopoulos, V ^c   Konstantinidou, A ^d   Spandidos, D A ^c   Papantoniou, N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

Angiogenesis; Angiopoietin 1; Angiopoietin 2; Placenta; Preeclampsia; Tie 2

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; MESSENGER RNA; ANGPT1 PROTEIN, HUMAN; ANGPT2 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; METABOLISM; PREGNANCY; YOUNG ADULT;

ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, TIE-2; YOUNG ADULT;

EID: 84906794212     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2014.07.001     Document Type: Article

References (45)

1. E.A. Steegers, P. von Dadelszen, J.J. Duvekot, and R. Pijnenborg Pre-eclampsia Lancet 376 2010 631 644
2. C.E. Kleinrouweler, M.M. Wiegerinck, C. Ris-Stalpers, P.M. Bossuyt, J.A. van der Post, P. von Dadelszen EBM CONNECT Collaboration Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis BJOG 119 2012 778 787
3. T. Chaiworapongsa, R. Romero, S.J. Korzeniewski, J.P. Kusanovic, E. Soto, and J. Lam et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia Am J Obstet Gynecol 208 2013 287.e1-287.e15
4. V. Gourvas, E. Dalpa, A. Konstantinidou, N. Vrachnis, D.A. Spandidos, and S. Sifakis Angiogenic factors in placentas from pregnancies complicated by fetal growth restriction (review) Mol Med Rep 6 2012 23 27
5. S.E. Maynard, and S.A. Karumanchi Angiogenic factors and preeclampsia Semin Nephrol 31 2011 33 46
6. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
7. Y. Seval, L. Sati, C. Celik-Ozenci, O. Taskin, and R. Demir The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta Placenta 29 2008 809 815
8. G. Thurston Role of angiopoietins and tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis Cell Tissue Res 314 2003 61 68
9. 2 that disrupts in vivo angiogenesis Science 277 1997 55 60
10. 2 receptor, by secretion-trap expression cloning Cell 87 1996 1161 1169
11. 2 J Cell Biol 169 2005 239 243
12. C. Suri, J. McClain, G. Thurston, D.M. McDonald, H. Zhou, and E.H. Oldmixon et al. Increased vascularization in mice overexpressing angiopoietin-1 Science 282 1998 468 471
13. 2 J Biol Chem 273 1998 18514 18521
14. C. Dunk, M. Shams, S. Nijjar, M. Rhaman, Y. Qiu, and B. Bussolati et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development Am J Pathol 156 2000 2185 2199
15. D.S. Goldman-Wohl, I. Ariel, C. Greenfield, Y. Lavy, and S. Yagel Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling Mol Hum Reprod 6 2000 81 87
16. E. Geva, D.G. Ginzinger, C.J. Zaloudek, D.H. Moore, A. Byrne, and R.B. Jaffe Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 J Clin Endocrinol Metab 87 2002 4213 4224
17. 2 in normal and pathologic human placentae Mol Med 7 2001 624 635
18. 2 receptor, during embryonic angiogenesis Cell 87 1996 1171 1180
19. T.N. Sato, Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, and M. Gendron-Maguire et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation Nature 376 1995 70 74
20. N.W. Gale, G. Thurston, S.F. Hackett, R. Renard, Q. Wang, and J. McClain et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1 Dev Cell 3 2002 411 423
21. S.Y. Han, J.K. Jun, C.H. Lee, J.S. Park, and H.C. Syn Angiopoietin-2: a promising indicator for the occurrence of severe preeclampsia Hypertens Pregnancy 31 2012 189 199
22. J.F. Sung, X. Fan, S. Dhal, B.K. Dwyer, A. Jafari, and Y.Y. El-Sayed et al. Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling J Clin Endocrinol Metab 96 2011 E1148 E1152
23. P. Vuorela, M.T. Matikainen, P. Kuusela, O. Ylikorkala, K. Alitalo, and E. Halmesmäki Endothelial tie receptor antigen in maternal and cord blood of healthy and preeclamptic subjects Obstet Gynecol 92 1998 179 183
24. K. Hirokoshi, Y. Maeshima, K. Kobayashi, E. Matsuura, H. Sugiyama, and Y. Yamasaki et al. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia Am J Hypertens 18 2005 1181 1188
25. K. Hirokoshi, Y. Maeshima, K. Kobayashi, E. Matsuura, H. Sugiyama, and Y. Yamasaki et al. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia Nephron Clin Pract 106 2007 c43 50
26. Y. Wang, V. Tasevski, E.M. Wallace, E.D. Gallery, and J.M. Morris Reduced maternal serum concentrations of angiopoietin-2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency BJOG 114 2007 1427 1431
27. F. Gotsch, R. Romero, J.P. Kusanovic, T. Chaiworapongsa, M. Dombrowski, and O. Erez et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2 J Matern Fetal Neonatal Med 21 2008 389 402
28. R. Akolekar, D. Casagrandi, E. Skyfta, A.A. Ahmed, and K.H. Nicolaides Maternal serum angiopoietin-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy Prenat Diagn 29 2009 847 851
29. M. Bolin, E. Wiberg-Itzel, A.K. Wikström, M. Goop, A. Larsson, and M. Olovsson et al. Angiopoietin-1/angiopoietin-2 ratio for prediction of preeclampsia Am J Hypertens 22 2009 891 895
30. E. Leinonen, K.A. Wathén, H. Alfthan, O. Ylikorkala, S. Andersson, and U.H. Stenman et al. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation J Clin Endocrinol Metab 95 2010 126 133
31. M. Kamal, and W. El-Khayat Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia? J Investig Med 59 2011 1147 1150
32. L.J. Salomon, Z. Alfirevic, V. Berghella, C. Bilardo, E. Hernandez-Andrade, and S.L. Johnsen et al. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan Ultrasound Obstet Gynecol 37 2011 116 126
33. F.P. Hadlock, R.B. Harrist, R.S. Sharman, R.L. Deter, and S.K. Park Estimation of fetal weight with the use of head, body, and femur measurement- a prospective study Am J Obstet Gynecol 151 1985 333 337
34. A.P. Souka, I. Papastefanou, A. Pilalis, V. Michalitsi, P. Panagopoulos, and D. Kassanos Performance of the ultrasound examination in the early and late third trimester for the prediction of birth weight deviations Prenat Diagn 33 2013 915 920
35. ACOG Committee on Practice Bulletins-Obstetrics ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002 Obstet Gynecol 99 2002 159 167
36. V.P. Androutsopoulos, and D.A. Spandios The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and p53/p21 upregulation J Nutr Biochem 24 2013 496 504
37. V. Gourvas, S. Sifakis, E. Dalpa, N. Soulitzis, O. Koukoura, and D.A. Spandidos Reduced placental prolyl hydroxylase 3 mRNA expression in pregnancies affected by fetal growth restriction BJOG 117 2010 1635 1642
38. H.A. Hou, W.C. Chou, L.I. Lin, J.L. Tang, M.H. Tseng, and C.F. Huang et al. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia Leuk Res 32 2008 904 912
39. C. Wulff, H. Wilson, S.E. Dickson, S.J. Wiegand, and H.M. Fraser Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy Biol Reprod 66 2002 802 812
40. V.W. van Hinsbergh, and G.P. van Nieuw Amerongen Intracellular signalling involved in modulating human endothelial barrier function J Anat 200 2002 549 560
41. R.B. Wysolmerski, and D. Lagunoff Involvement of myosin light-chain kinase in endothelial cell retraction Proc Natl Acad Sci U S A 87 1990 16 20
42. R. Sheldon, A. Moy, K. Lindsley, S. Shasby, and D.M. Shasby Role of myosin light-chain phosphorylation in endothelial cell retraction Am J Physiol 265 1993 606 612
43. S.M. Parikh, T. Mammoto, A. Schultz, H.T. Yuan, D. Christiani, and S.A. Karumanchi et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans PLoS Med 3 2006 e46
44. U. Fiedler, Y. Reiss, M. Scharpfenecker, V. Grunow, S. Koidl, and G. Thurston et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation Nat Med 12 2006 235 239
45. F. Roviezzo, S. Tsigkos, A. Kotanidou, M. Bucci, V. Brancaleone, and G. Cirino et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage J Pharmacol Exp Ther 314 2005 7